220 related articles for article (PubMed ID: 19351740)
1. Orphan targets for reperfusion injury.
Inserte J; Barrabés JA; Hernando V; Garcia-Dorado D
Cardiovasc Res; 2009 Jul; 83(2):169-78. PubMed ID: 19351740
[TBL] [Abstract][Full Text] [Related]
2. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
Garcia-Dorado D; Ruiz-Meana M; Piper HM
Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
[No Abstract] [Full Text] [Related]
3. Myocardial protection against reperfusion injury: the cGMP pathway.
Garcia-Dorado D; Agulló L; Sartorio CL; Ruiz-Meana M
Thromb Haemost; 2009 Apr; 101(4):635-42. PubMed ID: 19350105
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
[TBL] [Abstract][Full Text] [Related]
5. Calcium-mediated cell death during myocardial reperfusion.
Garcia-Dorado D; Ruiz-Meana M; Inserte J; Rodriguez-Sinovas A; Piper HM
Cardiovasc Res; 2012 May; 94(2):168-80. PubMed ID: 22499772
[TBL] [Abstract][Full Text] [Related]
6. Lethal myocardial reperfusion injury: a necessary evil?
Ibanez B; Fuster V; Jiménez-Borreguero J; Badimon JJ
Int J Cardiol; 2011 Aug; 151(1):3-11. PubMed ID: 21093938
[TBL] [Abstract][Full Text] [Related]
7. The first minutes of reperfusion: a window of opportunity for cardioprotection.
Piper HM; Abdallah Y; Schäfer C
Cardiovasc Res; 2004 Feb; 61(3):365-71. PubMed ID: 14962469
[TBL] [Abstract][Full Text] [Related]
8. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion.
Garcia-Dorado D; Rodriguez-Sinovas A; Ruiz-Meana M; Inserte J; Agulló L; Cabestrero A
Cardiovasc Res; 2006 May; 70(2):274-85. PubMed ID: 16635642
[TBL] [Abstract][Full Text] [Related]
9. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
10. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction.
Rodríguez-Sinovas A; Abdallah Y; Piper HM; Garcia-Dorado D
Heart Fail Rev; 2007 Dec; 12(3-4):207-16. PubMed ID: 17530396
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological therapy for myocardial reperfusion injury.
Moukarbel GV; Ayoub CM; Abchee AB
Curr Opin Pharmacol; 2004 Apr; 4(2):147-53. PubMed ID: 15063358
[TBL] [Abstract][Full Text] [Related]
12. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage.
Inserte J; Barba I; Hernando V; Abellán A; Ruiz-Meana M; Rodríguez-Sinovas A; Garcia-Dorado D
Cardiovasc Res; 2008 Mar; 77(4):782-90. PubMed ID: 18056767
[TBL] [Abstract][Full Text] [Related]
13. Benefits of reperfusion beyond infarct size limitation.
Takemura G; Nakagawa M; Kanamori H; Minatoguchi S; Fujiwara H
Cardiovasc Res; 2009 Jul; 83(2):269-76. PubMed ID: 19176600
[TBL] [Abstract][Full Text] [Related]
14. Signalling pathways in ischaemic postconditioning.
Hausenloy DJ
Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
[TBL] [Abstract][Full Text] [Related]
15. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Ovize M; Baxter GF; Di Lisa F; Ferdinandy P; Garcia-Dorado D; Hausenloy DJ; Heusch G; Vinten-Johansen J; Yellon DM; Schulz R;
Cardiovasc Res; 2010 Aug; 87(3):406-23. PubMed ID: 20448097
[TBL] [Abstract][Full Text] [Related]
16. Loss of cardioprotection with ageing.
Boengler K; Schulz R; Heusch G
Cardiovasc Res; 2009 Jul; 83(2):247-61. PubMed ID: 19176601
[TBL] [Abstract][Full Text] [Related]
17. Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations.
Monassier JP
Arch Cardiovasc Dis; 2008; 101(7-8):491-500. PubMed ID: 18848692
[TBL] [Abstract][Full Text] [Related]
18. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion.
García-Dorado D; Rodríguez-Sinovas A; Ruiz-Meana M
Cardiovasc Res; 2004 Feb; 61(3):386-401. PubMed ID: 14962471
[TBL] [Abstract][Full Text] [Related]
19. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart.
Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571
[TBL] [Abstract][Full Text] [Related]
20. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.
Oerlemans MI; Koudstaal S; Chamuleau SA; de Kleijn DP; Doevendans PA; Sluijter JP
Int J Cardiol; 2013 May; 165(3):410-22. PubMed ID: 22459400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
